1. Home
  2. PHVS vs PLPC Comparison

PHVS vs PLPC Comparison

Compare PHVS & PLPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • PLPC
  • Stock Information
  • Founded
  • PHVS 2015
  • PLPC 1947
  • Country
  • PHVS Switzerland
  • PLPC United States
  • Employees
  • PHVS N/A
  • PLPC N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • PLPC Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • PHVS Health Care
  • PLPC Industrials
  • Exchange
  • PHVS Nasdaq
  • PLPC Nasdaq
  • Market Cap
  • PHVS 980.9M
  • PLPC 789.5M
  • IPO Year
  • PHVS 2021
  • PLPC N/A
  • Fundamental
  • Price
  • PHVS $22.32
  • PLPC $167.32
  • Analyst Decision
  • PHVS Buy
  • PLPC
  • Analyst Count
  • PHVS 6
  • PLPC 0
  • Target Price
  • PHVS $37.17
  • PLPC N/A
  • AVG Volume (30 Days)
  • PHVS 33.8K
  • PLPC 165.3K
  • Earning Date
  • PHVS 08-13-2025
  • PLPC 07-30-2025
  • Dividend Yield
  • PHVS N/A
  • PLPC 0.48%
  • EPS Growth
  • PHVS N/A
  • PLPC N/A
  • EPS
  • PHVS N/A
  • PLPC 7.89
  • Revenue
  • PHVS N/A
  • PLPC $601,351,000.00
  • Revenue This Year
  • PHVS N/A
  • PLPC N/A
  • Revenue Next Year
  • PHVS N/A
  • PLPC N/A
  • P/E Ratio
  • PHVS N/A
  • PLPC $21.21
  • Revenue Growth
  • PHVS N/A
  • PLPC N/A
  • 52 Week Low
  • PHVS $11.51
  • PLPC $109.01
  • 52 Week High
  • PHVS $25.76
  • PLPC $171.94
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 73.31
  • PLPC 67.81
  • Support Level
  • PHVS $17.63
  • PLPC $164.32
  • Resistance Level
  • PHVS $19.00
  • PLPC $171.94
  • Average True Range (ATR)
  • PHVS 1.20
  • PLPC 5.91
  • MACD
  • PHVS 0.35
  • PLPC 0.37
  • Stochastic Oscillator
  • PHVS 92.15
  • PLPC 80.70

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.

Share on Social Networks: